Alaunos Therapeutics, Inc.
USD2.05
-0.02 (-0.97%)
CEO
Holger Weis
IPO Date
2005-08-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.06
Prev. Close
$2.07
Day Low
$2.01
Day High
$2.06
52W Low
$1.67
52W High
$4.59
Market Cap
$0.01B
Volume
0.00M
| 7,761 |
| $2.26 |
| 27 May 2026 | Weis Holger | Chief Executive Officer | A-Award | Acquired | 3,700 | $2.37 |
| 1 May 2026 | Vieser Jaime | director | A-Award | Acquired | 6,515 | $2.59 |
| 1 May 2026 | Postma Robert W | director | A-Award | Acquired | 6,274 | $2.59 |
| 1 May 2026 | Jerman Michael Allen | director | A-Award | Acquired | 6,032 | $2.59 |
| 15 Jan 2026 | Jerman Michael Allen | director | A-Award | Acquired | 5,406 | $2.89 |
| 15 Jan 2026 | Postma Robert W | director | A-Award | Acquired | 5,622 | $2.89 |
| 15 Jan 2026 | Vieser Jaime | director | A-Award | Acquired | 5,839 | $2.89 |
| 26 Nov 2025 | Vieser Jaime | director | A-Award | Acquired | 5,340 | $3.16 |